These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30502844)

  • 1. Primary thromboembolic prevention in multiple myeloma patients: An exploratory meta-analysis on aspirin use.
    Zoppellaro G; Veronese N; Granziera S; Gobbi L; Stubbs B; Cohen AT
    Semin Hematol; 2018 Oct; 55(4):182-184. PubMed ID: 30502844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboprophylaxis in multiple myeloma patients treated with lenalidomide - A systematic review.
    Al-Ani F; Bermejo JM; Mateos MV; Louzada M
    Thromb Res; 2016 May; 141():84-90. PubMed ID: 26986753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin in the primary prophylaxis of venous thromboembolism in surgical patients.
    Sahebally SM; Healy D; Walsh SR
    Surgeon; 2015 Dec; 13(6):348-58. PubMed ID: 26071929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What are the difficulties in conducting randomised controlled trials of thromboprophylaxis in myeloma patients and how can we address these? Lessons from apixaban versus LMWH or aspirin as thromboprophylaxis in newly diagnosed multiple myeloma (TiMM) feasibility clinical trial.
    Sayar Z; Czuprynska J; Patel JP; Benjamin R; Roberts LN; Patel RK; Cornelius V; Arya R
    J Thromb Thrombolysis; 2019 Aug; 48(2):315-322. PubMed ID: 31168688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin versus aspirin thromboprophylaxis adds independent value to IMPEDE-VTE score for venous thrombosis prediction in multiple myeloma.
    Bravo-Perez C; Fernández-Caballero M; Soler-Espejo E; Garcia-Torralba E; Sorigue M; García-Malo MD; Jerez A; Vicente V; Roldán V; de Arriba F
    J Thromb Thrombolysis; 2021 Oct; 52(3):848-853. PubMed ID: 33649980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobile Compression Reduces Bleeding-related Readmissions and Wound Complications After THA and TKA.
    Arsoy D; Giori NJ; Woolson ST
    Clin Orthop Relat Res; 2018 Feb; 476(2):381-387. PubMed ID: 29529673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective cohort study of venous thromboembolism(VTE) in 1035 Japanese myeloma patients treated with thalidomide; lower incidence without statistically significant association between specific risk factors and development of VTE and effects of thromboprophylaxis with aspirin and warfarin.
    Kato A; Takano H; Ichikawa A; Koshino M; Igarashi A; Hattori K; Nagata K
    Thromb Res; 2013 Feb; 131(2):140-4. PubMed ID: 23232090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MELISSE, a large multicentric observational study to determine risk factors of venous thromboembolism in patients with multiple myeloma treated with immunomodulatory drugs.
    Leleu X; Rodon P; Hulin C; Daley L; Dauriac C; Hacini M; Decaux O; Eisemann JC; Fitoussi O; Lioure B; Voillat L; Slama B; Al Jijakli A; Benramdane R; Chaleteix C; Costello R; Thyss A; Mathiot C; Boyle E; Maloisel F; Stoppa AM; Kolb B; Michallet M; Lamblin A; Natta P; Facon T; Elalamy I; Fermand JP; Moreau P
    Thromb Haemost; 2013 Oct; 110(4):844-51. PubMed ID: 23903204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Molecular-Weight Heparin and the Relative Risk of Surgical Site Bleeding Complications: Results of a Systematic Review and Meta-Analysis of Randomized Controlled Trials of Venous Thromboprophylaxis in Patients After Total Joint Arthroplasty.
    Suen K; Westh RN; Churilov L; Hardidge AJ
    J Arthroplasty; 2017 Sep; 32(9):2911-2919.e6. PubMed ID: 28522244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Rasmussen MS; Jørgensen LN; Wille-Jørgensen P
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004318. PubMed ID: 19160234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboprophylaxis in myeloma: what is happening outside of clinical trials?
    Crowley MP; Kevane B; Eustace JA; O'Shea S; Gilligan O
    Ir Med J; 2014 Oct; 107(9):281-4. PubMed ID: 25417387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Molecular-Weight Heparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Arthroscopic Surgery and Anterior Cruciate Ligament Reconstruction: A Meta-analysis of Randomized Controlled Trials.
    Zhu J; Jiang H; Marshall B; Li J; Tang X
    Am J Sports Med; 2019 Jul; 47(8):1994-2002. PubMed ID: 30113231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiple myeloma and venous thrombosis. Which thromboprophylaxis should be given?].
    de Moreuil C; Ianotto JC; Eveillard JR; Carrier M; Delluc A
    Rev Med Interne; 2016 Jul; 37(7):473-9. PubMed ID: 26833146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the venous thrombotic issues associated with multiple myeloma.
    Fotiou D; Gerotziafas G; Kastritis E; Dimopoulos MA; Terpos E
    Expert Rev Hematol; 2016 Jul; 9(7):695-706. PubMed ID: 27232265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-discharge adherence with venous thromboembolism prophylaxis after orthopedic trauma: Results from a randomized controlled trial of aspirin versus low molecular weight heparin.
    Haac BE; Van Besien R; O'Hara NN; Slobogean GP; Manson TT; O'Toole RV; Johal H; Berger PZ; Reahl GB; Marinos D; Degani Y; Mascarenhas D; Connelly D; Scalea TM; Stein DM
    J Trauma Acute Care Surg; 2018 Apr; 84(4):564-574. PubMed ID: 29251700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial.
    Haac BE; O'Hara NN; Manson TT; Slobogean GP; Castillo RC; O'Toole RV; Stein DM;
    PLoS One; 2020; 15(8):e0235628. PubMed ID: 32745092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty.
    Wilson DG; Poole WE; Chauhan SK; Rogers BA
    Bone Joint J; 2016 Aug; 98-B(8):1056-61. PubMed ID: 27482017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism in multiple myeloma: current perspectives in pathogenesis.
    Uaprasert N; Voorhees PM; Mackman N; Key NS
    Eur J Cancer; 2010 Jul; 46(10):1790-9. PubMed ID: 20385482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fondaparinux Sodium Compared With Low-Molecular-Weight Heparins for Perioperative Surgical Thromboprophylaxis: A Systematic Review and Meta-analysis.
    Kumar A; Talwar A; Farley JF; Muzumdar J; Schommer JC; Balkrishnan R; Wu W
    J Am Heart Assoc; 2019 May; 8(10):e012184. PubMed ID: 31070069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of venous thromboembolic events with low-molecular-weight heparin in the non-major orthopaedic setting: meta-analysis of randomized controlled trials.
    Chapelle C; Rosencher N; Jacques Zufferey P; Mismetti P; Cucherat M; Laporte S;
    Arthroscopy; 2014 Aug; 30(8):987-96. PubMed ID: 24813323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.